On April 9–10, the Co-Chair of TBEC Board and the TBEC Advocacy and Policy Manager attended the 13th Meeting of the European Technical Advisory Group on Tuberculosis (TAG-TB).

Throughout two days, TAG-TB members discussed:

  • the latest TB data: 3.6 million people with TB are still not diagnosed;
  • need to strengthen government officials’ capacity to fight TB;
  • importance of working with key groups and especially with migrants;
  • it was announced that at the end of 2019, new recommendations for MDR-TB treatment will be issued;
  • the need for advocacy for tests to define resistance to the 2nd line of drugs, especially to new ones such as Bedaquiline and Delamanid, etc;
  • the need to develop recommendations for the treatment of latent TB, because there are goals after United Nations High-Level Meeting on Tuberculosis (UN HLM on TB) that will not be achievable if there are no recommendations;
  • the need for advocacy for more UN HLMs that will be related to specific health diseases (such as TB, HIV, etc), as it was announced that the UN HLM on TB was the last meeting dedicated to a specific disease. Further meetings will be confined to the general topic of public health.

Among other subjects, a specific attention was given to a “new” framework for monitoring the implementation of the TB Action Plan for the WHO European Region post 2020.

Members of the TAG-TB Group stand in a group

During the TAG-TB meeting, TBEC voiced its concerns that WHO and agenda of such meetings should pay significant attention to what is next after the UN HLM on TB that was held in September 2018, as 2019 is the key year to monitor of the progress made towards meeting targets to end TB. We need to keep governments accountable and not to miss such an important moment in history.

TBEC is looking forward to hearing more discussions on the progress and implementation of the Political Declaration towards agreed TB goals at national, regional and global levels.

A report with recommendations from the TAG-TB group to the WHO Regional Director for Europe is available here.


This webpage is the product of an activity that has received funding under an operating grant from the European Union’s Health Programme (2014-2020).

The content of this webpage represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.